Annual Accounts Receivable
$129.12 M
+$13.66 M+11.83%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual accounts receivable is $129.12 million, with the most recent change of +$13.66 million (+11.83%) on December 31, 2023.
- During the last 3 years, IRWD annual accounts receivable has risen by +$6.77 million (+5.53%).
- IRWD annual accounts receivable is now at all-time high.
Performance
IRWD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$76.20 M
+$18.09 M+31.14%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly accounts receivable is $76.20 million, with the most recent change of +$18.09 million (+31.14%) on September 30, 2024.
- Over the past year, IRWD quarterly accounts receivable has stayed the same.
- IRWD quarterly accounts receivable is now -40.98% below its all-time high of $129.12 million, reached on December 31, 2023.
Performance
IRWD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IRWD Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.8% | 0.0% |
| 3 y3 years | +5.5% | -33.2% |
| 5 y5 years | +59.5% | -33.2% |
IRWD Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.2% | -41.0% | +31.1% |
| 5 y | 5-year | at high | +13.2% | -41.0% | +31.1% |
| alltime | all time | at high | >+9999.0% | -41.0% | >+9999.0% |
Ironwood Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $76.20 M(+31.1%) |
| Jun 2024 | - | $58.11 M(-19.3%) |
| Mar 2024 | - | $72.02 M(-44.2%) |
| Dec 2023 | $129.12 M(+11.8%) | $129.12 M(+3.7%) |
| Sep 2023 | - | $124.55 M(+4.7%) |
| Jun 2023 | - | $118.99 M(+2.8%) |
| Mar 2023 | - | $115.75 M(+0.3%) |
| Dec 2022 | $115.46 M(+1.2%) | $115.46 M(-0.9%) |
| Sep 2022 | - | $116.55 M(+13.9%) |
| Jun 2022 | - | $102.36 M(-3.0%) |
| Mar 2022 | - | $105.52 M(-7.5%) |
| Dec 2021 | $114.04 M(-6.8%) | $114.04 M(+12.1%) |
| Sep 2021 | - | $101.77 M(-0.5%) |
| Jun 2021 | - | $102.25 M(+17.3%) |
| Mar 2021 | - | $87.15 M(-28.8%) |
| Dec 2020 | $122.35 M(+4.4%) | $122.35 M(+8.0%) |
| Sep 2020 | - | $113.25 M(+7.5%) |
| Jun 2020 | - | $105.38 M(+15.7%) |
| Mar 2020 | - | $91.11 M(-22.3%) |
| Dec 2019 | $117.25 M(+44.8%) | $117.25 M(+21.4%) |
| Sep 2019 | - | $96.57 M(-7.0%) |
| Jun 2019 | - | $103.79 M(+42.9%) |
| Mar 2019 | - | $72.62 M(-10.3%) |
| Dec 2018 | $80.95 M(-1.5%) | $80.95 M(+23.8%) |
| Sep 2018 | - | $65.38 M(-18.8%) |
| Jun 2018 | - | $80.52 M(+14.0%) |
| Mar 2018 | - | $70.65 M(-14.0%) |
| Dec 2017 | $82.16 M(+26.7%) | $82.16 M(+2.6%) |
| Sep 2017 | - | $80.08 M(+32.7%) |
| Jun 2017 | - | $60.36 M(+18.0%) |
| Mar 2017 | - | $51.15 M(-21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $64.85 M(+19.0%) | $64.85 M(+20.7%) |
| Sep 2016 | - | $53.72 M(+1.1%) |
| Jun 2016 | - | $53.15 M(+0.2%) |
| Mar 2016 | - | $53.02 M(-2.8%) |
| Dec 2015 | $54.52 M(+111.0%) | $54.52 M(+47.5%) |
| Sep 2015 | - | $36.97 M(+36.7%) |
| Jun 2015 | - | $27.05 M(-20.1%) |
| Mar 2015 | - | $33.85 M(+31.0%) |
| Dec 2014 | $25.84 M(+704.2%) | $25.84 M(+75.9%) |
| Sep 2014 | - | $14.69 M(+229.7%) |
| Jun 2014 | - | $4.46 M(-56.9%) |
| Mar 2014 | - | $10.34 M(+221.7%) |
| Dec 2013 | $3.21 M(+116.1%) | $3.21 M(+4.1%) |
| Sep 2013 | - | $3.09 M(-41.8%) |
| Jun 2013 | - | $5.30 M(>+9900.0%) |
| Mar 2013 | - | $48.00 K(-96.8%) |
| Dec 2012 | $1.49 M(+128.1%) | $1.49 M(+717.0%) |
| Sep 2012 | - | $182.00 K(-92.6%) |
| Jun 2012 | - | $2.47 M(+2162.4%) |
| Mar 2012 | - | $109.00 K(-83.3%) |
| Dec 2011 | $652.00 K(-77.5%) | $652.00 K(-12.0%) |
| Sep 2011 | - | $741.00 K(-71.8%) |
| Jun 2011 | - | $2.63 M(-37.2%) |
| Mar 2011 | - | $4.18 M(+44.5%) |
| Dec 2010 | $2.90 M(-44.5%) | $2.90 M(-54.4%) |
| Jun 2010 | - | $6.35 M(+34.5%) |
| Mar 2010 | - | $4.72 M(-9.5%) |
| Dec 2009 | $5.22 M(+9.4%) | $5.22 M(-47.4%) |
| Sep 2009 | - | $9.92 M(+108.0%) |
| Dec 2008 | $4.77 M(-81.3%) | $4.77 M |
| Dec 2007 | $25.51 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual accounts receivable year-on-year change?
- What is Ironwood Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Ironwood Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of IRWD is $129.12 M
What is the all time high annual accounts receivable for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual accounts receivable is $129.12 M
What is Ironwood Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, IRWD annual accounts receivable has changed by +$13.66 M (+11.83%)
What is Ironwood Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of IRWD is $76.20 M
What is the all time high quarterly accounts receivable for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly accounts receivable is $129.12 M
What is Ironwood Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, IRWD quarterly accounts receivable has changed by $0.00 (0.00%)